FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a method for producing an amorphous form of N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indole-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrol-3-carboxamide malate. The method includes the following stages: (a) fusing crystalline N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indole-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide malate, D-fructose and urea in a mass ratio of 1:2:3, at a temperature of 60°C while stirring; (b) adding water to the resulting melt; (c) stirring the resulting mixture; (d) filtering the precipitate; (e) preparing a suspension of precipitate in water; (f) stirring the resulting suspension at a temperature of 20°C; (g) filtering the precipitate; (h) washing the precipitate with water on a filter; (i) drying the precipitate until a constant mass under vacuum at a temperature of 40°C.
EFFECT: production of an amorphous form of N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indole-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide malate, containing a reduced amount of impurities.
2 cl, 8 dwg, 8 tbl, 12 ex
Title |
Year |
Author |
Number |
CRYSTALLINE ε-MODIFICATION OF N-[2-(DIETHYLAMINO)ETHYL]-5-[(Z)-(5-FLUOR-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALATE, METHOD FOR PRODUCING SAME AND BASED PHARMACEUTICAL COMPOSITION |
2014 |
- Malin Aleksandr Aleksandrovich
- Mikhajlov Oleg Rostislavovich
- Uvarov Nikolaj Aleksandrovich
|
RU2567535C1 |
NONHYGROSCOPIC CRYSTALLINE 5-[(Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[(2S)-2-HYDROXY-3-MORPHOLIN-4-YLPROPYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALEATE SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR CANCER TREATMENT |
2004 |
- Blasko Andrej
- Tszin' Tsinvu
- Lu Tsjun'
- Morejdzhis Majkl Ehntoni
- Song Dong
- Vondervell Brenda S'Ju
|
RU2319702C2 |
METHOD FOR PREPARING INDOLINONE DERIVATIVES |
2003 |
- Dzin Kvingvu
- Mauragis Majkl A.
- Mehj Pol D.
|
RU2299209C2 |
DERIVATIVES OF INDOLIN-2-SHE AS INHIBITORS OF PROTEINKINAS |
2013 |
- Chern Tszi-Van
- Dzhagtap Atszit Dkhanandzhej
- Van Khsyao-Chun
- Chen Grejs Shiakhu
|
RU2627706C2 |
PRODRUGS OF 3-ACYL-2-HYDROXYINDOLE-1-CARBOXAMIDES, PHARMACEUTICAL COMPOSITION |
1993 |
- Vejn E.Bart
- Kelvin Kuper
- Ehdvard F.Klejnman
- Lourens A.Rejter
- Ral'F P.Robinson
|
RU2124514C1 |
2-(2-OXOINDOLIN-3-YLIDENE)METHYL-5-(2-HYDROXY-3-MORPHOLIN-4-YLPROPYL)-6,7-DIHYDRO-1-H-PYRROLE[3,2-C]PYRIDIN-4(5H)-ONE COMPOUNDS AND USE THEREOF AS PROTEIN KINASE INHIBITORS |
2008 |
- Tan Pehn Chzho
- Jan Tszjaljan
- Su Idun
- Chzhao Futsjan
|
RU2472792C2 |
N-ALKYL-N-{[3-ALKYL-3,8-DIAZABICYCLO[3_2_1]OCTA-1(7),5-DIEN-8-YL]METHYL}AMINES, HAVING CYTOTOXIC ACTIVITY ON HEK 293 CELL LINE |
2019 |
- Akhmetova Vnira Rakhimovna
- Bikbulatova Elmira Minurovna
- Akhmadiev Nail Salavatovich
- Abdullina Zilya Yamilovna
- Ibragimov Askhat Gabdrakhmanovich
- Dzhemilev Usein Memetovich
|
RU2726120C1 |
HETEROCYCLIC NITROGEN PYRROLE DERIVATIVES, PRODUCING THEM AND PHARMACEUTICAL APPLICATION |
2008 |
- Tan Pehn Chzho
- Su Idun
- Li Jali
- Chzhan Lehj
- Chzhao Futsjan
- Jan Tszjaljan
- Chzhou In
- Bieh Pinjan'
- Tsjan' Guan'Tao
- Tszjuj Mingan
|
RU2473543C2 |
1-SULFONYL-1,3-DIHYDROINDOLE-2-ONES, PHARMACEUTICAL COMPOSITIONS (VARIANTS), METHOD FOR THEIR PREPARING AND APPLYING |
2003 |
- Ivashchenko A.V.
- Khvat Aleksandr Viktorovich
- Kravchenko D.V.
- Tkachenko S.E.
- Okun' Il'Ja Matusovich
|
RU2259999C2 |
NEW CRYSTALLINE FORM OF 2-{3-[2-(1-{[3,5-BIS(DIFLUOROMETHYL)-1H-PYRAZOL-1-YL]ACETYL}PIPERIDIN-4-YL)-1,3-THIAZOL-4-YL]-4,5-DIHYDRO-1,2-OXAZOL-5-YL}-3-CHLOROPHENYLMETHANE SULPHONATE |
2014 |
- Olenik Britta
- Khillebrand Shtefan
- Vasner Perr
- Vajss Martin
- Vakhendorff-Nojmann Ulrike
|
RU2691948C2 |